Abstract
Despite recent outcome improvement, liver transplantation from donation after circulatory death (DCD) donors remains a challenge. Multiple donor, graft and procurement factors not only contribute to the results after transplantation but also impact on the selection process and the decision to utilize or decline such livers, which potentially transmit a high risk for severe complications including primary graft non-function or ischemic cholangiopathy. Although the transplant community has gained significant experience in this field, the majority of risk factors is still inconsistently reported with various acceptance criteria and thresholds, when to accept a DCD donor liver, which also depends on national and centre guidelines and the surgeons’ experience. Throughout the past 10 years, we have developed an increasing awareness of the cumulative risk and how to best combine donor and recipient parameters, which encouraged the community to adapt the allocation process and to match certain DCD livers with presumed higher risk with healthier recipients, as, for example, with candidates with liver tumours. In this chapter, we highlight currently considered donor and graft risk factors and how they contribute to outcomes after transplantation. Additionally, we also describe the impact of donor surgery and current prediction models which may influence the DCD liver selection process and how we may expect new developments and preservation technology to impact on our decisions in the future.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- ALT:
-
Alanine aminotransferase
- AST:
-
Aspartate aminotransferase
- BMI:
-
Body max index
- CIT:
-
Cold ischemia time
- CVA:
-
cerebrovascular accident
- DAA:
-
Direct-acting antiviral medications
- DBD:
-
Donation after brain death
- DCD:
-
Donation after circulatory death
- DCD-RI:
-
DCD-risk index
- DM:
-
Diabetes mellitus
- DRI:
-
Donor risk index
- ET-DRI:
-
Eurotransplant Donor Risk Index
- fDWIT:
-
Functional donor warm ischemia time
- GGT:
-
Gammy-glutamyl-transferase
- HBV:
-
Hepatitis B virus
- HCC:
-
Hepatocellular carcinoma
- HCV:
-
Hepatitis C virus
- HMP:
-
Hypothermic machine perfusion
- HOPE:
-
Hypothermic oxygenated perfusion
- IC:
-
Ischemic cholangiopathy
- ITU:
-
Intensive care unit
- KCH:
-
King’s College Hospital
- MELD:
-
Model of End Liver Disease
- NHS:
-
National Health Service
- NHSBT:
-
National Health Service Blood and Transplant
- NMP:
-
Normothermic machine perfusion
- NRP:
-
Normothermic regional perfusion
- PNF:
-
Primary non-function
- UCLA:
-
University of California at Los Angeles
- UHB:
-
University Hospitals Birmingham
- UK:
-
United Kingdom
- UK-DCD-Risk Score:
-
United Kingdom Donation after Circulatory Death Risk Score
- UNOS:
-
United Network of Organ Sharing
- USA:
-
United States of America
References
Abt PL, et al. Survival following liver transplantation from non-heart-beating donors. Ann Surg. 2004;239:87. https://doi.org/10.1097/01.sla.0000103063.82181.2c.
Agopian VG, et al. The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center. Ann Surg. 2013; https://doi.org/10.1097/SLA.0b013e3182a15db4.
Andrews PA, Burnapp L, Manas D. Summary of the British transplantation society guidelines for transplantation from donors after deceased circulatory death. Transplantation. 2014;97:265. https://doi.org/10.1097/01.TP.0000438630.13967.c0.
Baccarani U, Adani GL, Isola M, et al. Steatosis of the graft is a risk factor for posttransplantation biliary complications. Transplant Proc. 2009;41:1313.
Battula N, Bohorquez H, Seal J, Ahmed Bugeaud E, Bruce D, Carmody I, et al. Results of high risk donation-after-circulatory death (DCD) donor liver transplants. Am J Transplant. 2017;17(S2):19.
Belli LS, et al. Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: a European study. J Hepatol. 2016;65(3):524–31. https://doi.org/10.1016/j.jhep.2016.05.010.
Boteon Y, et al. Combined hypothermic and normothermic machine perfusion improves functional recovery of extended criteria donor livers. Liver Transpl. 2018. https://doi.org/10.1002/lt.25315.
Boteon A, et al. Retrieval practice or overall donor and recipient risk - what impacts on outcomes after DCD liver transplantation in the United Kingdom? Liver Transpl. 2019;25:545.
Braat AE, et al. The eurotransplant donor risk index in liver transplantation: ET-DRI. Am J Transplant. 2012a;12:2789. https://doi.org/10.1111/j.1600-6143.2012.04195.x.
Braat AE, et al. The eurotransplant donor risk index in liver transplantation: ET-DRI. Am J Transplant. 2012b;12(10):2789–96. https://doi.org/10.1111/j.1600-6143.2012.04195.x.
Briceño J, et al. Influence of marginal donors on liver preservation injury. Transplantation. 2002;74:522.
Briceño J, Ciria R, De La Mata M. Donor-recipient matching: myths and realities. J Hepatol. 2013;58(4):811–20. https://doi.org/10.1016/j.jhep.2012.10.020.
Buis CI, et al. Altered bile composition after liver transplantation is associated with the development of nonanastomotic biliary strictures. J Hepatol. 2009;50:69. https://doi.org/10.1016/j.jhep.2008.07.032.
Cao Y, et al. Donation after circulatory death for liver transplantation: a meta-analysis on the location of life support withdrawal affecting outcomes. Transplantation. 2016;100:1513. https://doi.org/10.1097/TP.0000000000001175.
Casavilla A, et al. Experience with liver and kidney allografts from non - heart-beating donors. Transplantation. 1995;59:197. https://doi.org/10.1097/00007890-199501000-00008.
Champigneulle B, et al. Hypoxic hepatitis after out-of-hospital cardiac arrest: incidence, determinants and prognosis. Resuscitation. 2016;103:60. https://doi.org/10.1016/j.resuscitation.2016.03.021.
Cheetham OV, et al. Rates of organ donation in a UK tertiary cardiac arrest centre following out-of-hospital cardiac arrest. Resuscitation. 2016;101:41. https://doi.org/10.1016/j.resuscitation.2016.01.003.
Chirichella TJ, et al. Donor preoperative oxygen delivery and post-extubation hypoxia impact donation after circulatory death hypoxic cholangiopathy. World J Gastroenterol. 2016;22:3392. https://doi.org/10.3748/wjg.v22.i12.3392.
Chouchani ET, et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature. 2014a;515(V):431–5. https://doi.org/10.1038/nature13909.
Chouchani ET, et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature. 2014b;515(7527):431–5. https://doi.org/10.1038/nature13909.
Choudhary NS, et al. Prediction of nonalcoholic fatty liver in prospective liver donors. Clin Transpl. 2017;31. https://doi.org/10.1111/ctr.12890.
Collett D, Friend PJ, Watson CJE. Factors associated with short- and long-term liver graft survival in the United Kingdom: development of a UK donor liver index. Transplantation. 2017;101:786. https://doi.org/10.1097/TP.0000000000001576.
Croome KP, et al. Improving national results in liver transplantation using grafts from donation after cardiac death donors. Transplantation. 2016;100:2640. https://doi.org/10.1097/TP.0000000000001483.
Croome KP, et al. Comparison of longterm outcomes and quality of life in recipients of donation after cardiac death liver grafts with a propensity-matched cohort. Liver Transpl. 2017a;23:342. https://doi.org/10.1002/lt.24713.
Croome KP, et al. Noneligible donors as a strategy to decrease the organ shortage. Am J Transplant. 2017b;17:1649. https://doi.org/10.1111/ajt.14163.
Croome KP, et al. Outcomes of donation after circulatory death liver grafts from donors 50 years or older: a multicenter analysis. Transplantation. 2018;102:1108. https://doi.org/10.1097/TP.0000000000002120.
Croome KP, Lee DD, Taner CB. The “skinny” on assessment and utilization of steatotic liver grafts: a systematic review. Liver Transpl. 2019;25(3):488–99.
Croome KP, Mathur AK, Mao S, Aqel B, Piatt J, Sedki A, Senada P, Heimbach JK, Moss A, Rosen CB, Taner CB. Peri-operative and longterm outcomes of utilizing donation after circulatory death liver grafts with macrosteatosis: a multicenter analysis. Am J Transplant. 2020 Mar 25. https://doi.org/10.1111/ajt.15877. [Epub ahead of print].
Dasari BVM, et al. The use of old donors in liver transplantation. Best Pract Res Clin Gastroenterol. 2017;31:211–7. https://doi.org/10.1016/j.bpg.2017.03.002.
Davila D, et al. Prediction models of donor arrest and graft utilization in liver transplantation from maastricht-3 donors after circulatory death. Am J Transplant. 2012;12:3414. https://doi.org/10.1111/j.1600-6143.2012.04242.x.
De Carlis R, et al. Successful donation after cardiac death liver transplants with prolonged warm ischemia time using normothermic regional perfusion. Liver Transpl. 2017;23:166. https://doi.org/10.1002/lt.24666.
De Carlis R, et al. Liver grafts from donors after circulatory death on regional perfusion with extended warm ischemia compared with donors after brain death. Liver Transpl. 2018;24:1523. https://doi.org/10.1002/lt.25312.
de Vries Y, et al. Pretransplant sequential hypo- and normothermic machine perfusion of suboptimal livers donated after circulatory death using a hemoglobin-based oxygen carrier perfusion solution. Am J Transplant. 2018;19:1202. https://doi.org/10.1111/ajt.15228.
de Vries Y, et al. Pretransplant sequential hypo- and normothermic machine perfusion of suboptimal livers donated after circulatory death using a hemoglobin-based oxygen carrier perfusion solution. Am J Transplant. 2019;19:1202. https://doi.org/10.1111/ajt.15228.
DeOliveira ML, et al. Biliary complications after liver transplantation using grafts from donors after cardiac death: results from a matched control study in a single large volume center. Ann Surg. 2011;254(5):716–22; discussion 722–3. https://doi.org/10.1097/SLA.0b013e318235c572.
Durand F, et al. Age and liver transplantation. J Hepatol. European Association for the Study of the Liver, (December). 2018. https://doi.org/10.1016/j.jhep.2018.12.009.
Dutkowski P, et al. Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the model for end-stage liver disease era. Ann Surg. 2011;254(5):745–53; discussion 753. https://doi.org/10.1097/SLA.0b013e3182365081.
Dutkowski P, et al. The use of fatty liver grafts in modern allocation systems: risk assessment by the balance of risk (BAR) score. Ann Surg. 2012;256(5):861–9. https://doi.org/10.1097/SLA.0b013e318272dea2.
Dutkowski P, et al. Evolving trends in machine perfusion for liver transplantation. Gastroenterology. 2019;156:1542. https://doi.org/10.1053/j.gastro.2018.12.037.
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu.EASL clinical practice guidelines: liver transplantation. J Hepatol. 2016;64:433. https://doi.org/10.1016/j.jhep.2015.10.006.
Farid SG, et al. Impact of donor hepatectomy time during organ procurement in donation after circulatory death liver transplantation. Transplantation. 2018;103:e79. https://doi.org/10.1097/TP.0000000000002518.
Feng S, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant. 2006;6(4):783–90. https://doi.org/10.1111/j.1600-6143.2006.01242.x.
Firl DJ, et al. Role of donor hemodynamic trajectory in determining graft survival in liver transplantation from donation after circulatory death donors. Liver Transpl. 2016;22:1469. https://doi.org/10.1002/lt.24633.
Foley DP, et al. Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcomes from a single center. Ann Surg. 2011;253(4):817–25. https://doi.org/10.1097/SLA.0b013e3182104784.
Frongillo F, Lirosi MC, Sganga G, Grossi U, Nure E, Avolio AW, Bianco G, Mariano G, Agnes S. Graft steatosis as a risk factor of ischemic-type biliary lesions in liver transplantation. Transplant Proc. 2014;46(7):2293–4.
Giorgakis E, et al. Minimization of ischemic cholangiopathy in donation after cardiac death liver transplantation: is it thrombolytic therapy or warm ischemic time stringency and donor bile duct flush? Am J Transplant. 2017. https://doi.org/10.1111/ajt.14429.
Goldberg DS, et al. Interpreting outcomes in DCDD liver transplantation: first report of the Multicenter IDOL Consortium. Transplantation. 2017;101(5):1067. https://doi.org/10.1097/TP.0000000000001656.
Guo G, et al. Clinical features of ischemic hepatitis caused by shock with four different types: a retrospective study of 328 cases. Int J Clin Exp Med. 2015;8(9):16670–5.
Halldorson JB, et al. Differential rates of ischemic cholangiopathy and graft survival associated with induction therapy in DCD liver transplantation. Am J Transplant. 2015;15:251. https://doi.org/10.1111/ajt.12962.
Hessheimer A, et al. Normothermic regional perfusion versus super rapid recovery in controlled donation after circulatory death liver transplantation. J Hepatol. 2018;70:658. https://doi.org/10.1016/j.jhep.2018.12.013.
Heylen L, et al. The duration of asystolic ischemia determines the risk of graft failure after circulatory-dead donor kidney transplantation: a Eurotransplant cohort study. Am J Transplant. 2018;18:881. https://doi.org/10.1111/ajt.14526.
Hodgson R, et al. Impact of a national controlled donation after circulatory death (DCD) program on organ donation in the United Kingdom: a 10-year study. Am J Transplant. 2017;17:3172. https://doi.org/10.1111/ajt.14374.
Hong JC, et al. Liver transplantation using organ donation after cardiac death: a clinical predictive index for graft failure-free survival. Arch Surg. 2011;146(9):1017–23. https://doi.org/10.1001/archsurg.2011.240.
Hoyer DP, et al. Controlled oxygenated rewarming of cold stored livers prior to transplantation: first clinical application of a new concept. Transplantation. 2016;100(1):147–52. https://doi.org/10.1097/TP.0000000000000915.
Jay C, et al. A comprehensive risk assessment of mortality following donation after cardiac death liver transplant - an analysis of the national registry. J Hepatol. 2011;55(4):808–13. Available at: http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed10&NEWS=N&AN=2011523559.
Jochmans I, et al. The impact of hepatectomy time of the liver graft on post-transplant outcome. Ann Surg. 2017:1. https://doi.org/10.1097/SLA.0000000000002593.
Joya-Vazquez PP, et al. Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis. Transplantation. 2002;73:1598. https://doi.org/10.1097/00007890-200205270-00013.
Kalisvaart M, et al. Onset of donor warm ischemia time in donation after circulatory death liver transplantation: hypotension or hypoxia? Liver Transpl. 2018;24:1001. https://doi.org/10.1002/lt.25287.
Kalisvaart M, Muiesan P, Schlegel A. The UK-DCD-Risk-Score - practical and new guidance for allocation of a specific organ to a recipient? Expert Rev Gastroenterol Hepatol. 2019;13(8):771–83. https://doi.org/10.1080/17474124.2019.1629286.
Kaltenbach M, et al. Trends in deceased donor liver enzymes prior to transplant: the impact on graft selection and outcomes. Am J Transplant. 2019;20:213. https://doi.org/10.1111/ajt.15573.
Kamei H, et al. Brain death organ donor supported by a left ventricular assist device showing unexpected congestive liver fibrosis: a case report. Int J Surg Case Rep. 2018;47:57. https://doi.org/10.1016/j.ijscr.2018.04.026.
Kauffman HM, et al. Donor-related malignancies. Transplant Rev. 2002;16:177. https://doi.org/10.1053/trte.2002.128240.
Khorsandi S, et al. Developing a donation after cardiac death risk index for adult and pediatric liver transplantation. World J Transplant. 2017;7(3):203–12. https://doi.org/10.5500/wjt.v7.i3.203.
Kim M, et al. Attenuation of oxidative damage by targeting mitochondrial complex I in neonatal hypoxic-ischemic brain injury. Free Radic Biol Med. 2018;124:517. https://doi.org/10.1016/j.freeradbiomed.2018.06.040.
Kron P, et al. Hypothermic oxygenated perfusion (HOPE) for fatty liver grafts in rats and humans. J Hepatol. 2018;68(1):82–91. https://doi.org/10.1016/j.jhep.2017.08.028.
Laing R, et al. Viability testing and transplantation of marginal livers (VITTAL) using normothermic machine perfusion: study protocol for an open-label, non-randomised, prospective, single-arm trial. BMJ Open. 2017;7(11). https://doi.org/10.1136/bmjopen-2017-017733.
Leithead JA, et al. Donation after cardiac death liver transplant recipients have an increased frequency of acute kidney injury. Am J Transplant. 2012;12:965. https://doi.org/10.1111/j.1600-6143.2011.03894.x.
Llop-Talaveron J, et al. Risk factors of hepatic function alterations in hospitalized adult patients treated with short-term parenteral nutrition receiving the same lipid composition at the same dose. Lipids Health Dis. 2018;17:267. https://doi.org/10.1186/s12944-018-0912-4.
López-Navidad A, Caballero F. Extended criteria for organ acceptance. Strategies for achieving organ safety and for increasing organ pool. Clin Transpl. 2003;17:308. https://doi.org/10.1034/j.1399-0012.2003.00119.x.
Mangus RS, et al. Elevated alanine aminotransferase (ALT) in the deceased donor: impact on early post-transplant liver allograft function. Liver Int. 2015;35:524. https://doi.org/10.1111/liv.12508.
Mangus RS, et al. Impact of donor pre-procurement cardiac arrest (PPCA) on clinical outcomes in liver transplantation. Ann Transplant. 2018. https://doi.org/10.12659/AOT.910387.
Manyalich M, Nelson H, Delmonico FL. The need and opportunity for donation after circulatory death worldwide. Curr Opin Organ Transplant. 2018;23:136. https://doi.org/10.1097/MOT.0000000000000486.
Marcon F, et al. Utilisation of declined liver grafts yields comparable transplant outcomes and previous decline should not be a deterrent to graft use. Transplantation. 2018. https://doi.org/10.1097/TP.0000000000002127.
Matton APM, et al. Biliary bicarbonate, pH and glucose are suitable biomarkers of biliary viability during ex situ normothermic machine perfusion of human donor livers. Transplantation. 2018;103:1405. https://doi.org/10.1097/TP.0000000000002500.
Mergental H, et al. Transplantation of declined liver allografts following normothermic ex-situ evaluation. Am J Transplant. 2016;16(11):3235–45. https://doi.org/10.1111/ajt.13875.
Monbaliu D, Pirenne J, Talbot D. Liver transplantation using donation after cardiac death donors. J Hepatol. 2012;56(2):474–85. https://doi.org/10.1016/j.jhep.2011.07.004.
Muiesan P, et al. Single-center experience with liver transplantation from controlled non-heartbeating donors: a viable source of grafts. Ann Surg. 2005;242:732. https://doi.org/10.1097/01.sla.0000186177.26112.d2.
Muller X, Schlegel A, Würdinger M, et al. Can hypothermic oxygenated perfusion (HOPE) rescue futile DCD liver grafts? HPB (Oxford). 2019a;21:1156.
Muller X, Schlegel A, Kron P, et al. Novel real-time prediction of liver graft function during hypothermic oxygenated machine perfusion prior to liver transplantation. Ann Surg. 2019b;270(5):783–90.
Nalesnik MA, et al. Donor-transmitted malignancies in organ transplantation: assessment of clinical risk. Am J Transplant. 2011;11:1140. https://doi.org/10.1111/j.1600-6143.2011.03565.x.
Nasralla D, et al. A randomized trial of normothermic preservation in liver transplantation. Nature. 2018;557:50. https://doi.org/10.1038/s41586-018-0047-9.
NHSBT. NHS Blood and Transplant annual report and accounts 2017 to 2018. 2018.
Oniscu G, Watson C, Wigmore S. Redefining futility in DCD liver transplantation in the era of novel perfusion technologies. J Hepatol. 2018;68(6):1327–8.
OPTN/UNOS. Annual report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients. 2018.
Perera MTPR, et al. Comparison of energy metabolism in liver grafts from donors after circulatory death and donors after brain death during cold storage and reperfusion. Br J Surg. 2014;101:775. https://doi.org/10.1002/bjs.9478.
Reich DJ, et al. ASTS recommended practice guidelines for controlled donation after cardiac death organ procurement and transplantation. Am J Transplant. 2009;9(9):2004–11. https://doi.org/10.1111/j.1600-6143.2009.02739.x.
Routh D, et al. Changing pattern of donor selection criteria in deceased donor liver transplant: a review of literature. J Clin Exp Hepatol. 2013;3(4):337–46. https://doi.org/10.1016/j.jceh.2013.11.007.
Scalea JR, Redfield RR, Foley DP. Liver transplant outcomes using ideal donation after circulatory death livers are superior to using older donation after brain death donor livers. Liver Transpl. 2016;22:1197. https://doi.org/10.1002/lt.24494.
Schlegel A, et al. Risk assessment in high and low MELD liver transplantation. Am J Transplant. 2016;10:1–14. https://doi.org/10.1111/ajt.14065.
Schlegel A, Kalisvaart M, Isaac J, et al. Reply to: “Redefining futility in DCD liver transplantation in the era of novel perfusion technologies”. J Hepatol. 2018a;68(6):1328–30. https://doi.org/10.1016/j.jhep.2018.03.003.
Schlegel A, Kalisvaart M, Scalera I, et al. The UK DCD Risk Score: a new proposal to define futility in donation-after-circulatory-death liver transplantation. J Hepatol. 2018b;68(3):456–64. https://doi.org/10.1016/j.jhep.2017.10.034.
Schlegel A, Muller X, Dutkowski P. Hypothermic machine preservation of the liver: state of the art. Curr Transplant Rep. 2018c;5:93. https://doi.org/10.1007/s40472-018-0183-z.
Schlegel A, et al. Impact of donor age in donation after cardiac death liver transplantation: is the cut-off “60” still of relevance? Liver Transpl. 2018d;24(3):352–62. https://doi.org/10.1002/lt.24865.
Schlegel A, Scalera I, et al. Reply. Liver Transpl. 2018e;24(4):563–4. https://doi.org/10.1002/lt.24949.
Schlegel A, et al. Reply to: “DCD consensus and futility in liver transplantation”. J Hepatol. 2018f;69(1):257–8. https://doi.org/10.1016/j.jhep.2018.04.001.
Schlegel AA, et al. Outcomes of liver transplantations from donation after circulatory death (DCD) treated by hypothermic oxygenated perfusion (HOPE) before implantation. J Hepatol. 2019;70(1):50–7. https://doi.org/10.1016/j.jhep.2018.10.005.
Schmucker DL. Age-related changes in liver structure and function: implications for disease ? Exp Gerontol. 2005;40(8–9):650–9. https://doi.org/10.1016/j.exger.2005.06.009.
Selten J, et al. Hypo- and normothermic perfusion of the liver: which way to go? Best Pract Res Clin Gastroenterol. 2017;31:171–9. https://doi.org/10.1016/j.bpg.2017.04.001.
Selzner M, Clavien PA. Fatty liver in liver transplantation and surgery. Semin Liver Dis. 2001;21:105–13. https://doi.org/10.1055/s-2001-12933.
Singhal A, et al. Hospital resource use with donation after cardiac death allografts in liver transplantation: a matched controlled analysis from 2007 to 2011. J Am Coll Surg. 2015;220:951. https://doi.org/10.1016/j.jamcollsurg.2015.01.052.
Skalski M, et al. Utilization of donors with hepatitis B core antibodies in liver transplantation. Ann Transplant. 2015. https://doi.org/10.12659/AOT.894127.
Spitzer AL, et al. The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment. Liver Transpl. 2010;16:874. https://doi.org/10.1002/lt.22085.
Sullivan LM, Massaro JM, D’Agostino RBS. Presentation of multivariate data for clinical use: the Framingham Study risk score functions. Stat Med. 2004;23(10):1631–60. https://doi.org/10.1002/sim.1742.
Taner CB, et al. Events in procurement as risk factors for ischemic cholangiopathy in liver transplantation using donation after cardiac death donors. Liver Transpl. 2012;18(1):101–12. https://doi.org/10.1002/lt.22404.
Thuong M, et al. New classification of donation after circulatory death donors definitions and terminology. Transpl Int. 2016;29:749–59. https://doi.org/10.1111/tri.12776.
Timchenko NA. Aging and liver regeneration. Trends Endocrinol Metab. 2009;20:171. https://doi.org/10.1016/j.tem.2009.01.005.
Tsui SSL, Oniscu GC. Extending normothermic regional perfusion to the thorax in donors after circulatory death. Curr Opin Organ Transplant. 2017;22:245–50. https://doi.org/10.1097/MOT.0000000000000413.
van Reeven M, et al. Donor hepatectomy time in donation after circulatory death donors is an independent risk factor for development of biliary strictures and early graft loss after transplantation. ILTS Conference Lisbon Portugal, Abstract(1). 2018, p. 1.
van Rijn R, et al. Hypothermic oxygenated machine perfusion reduces bile duct reperfusion injury after transplantation of donation after circulatory death livers. Liver Transpl. 2018. https://doi.org/10.1002/lt.25023.
Verhelst X, et al. Glycome patterns of perfusate in livers before transplantation associate with primary nonfunction. Gastroenterology. 2018;154:1361. https://doi.org/10.1053/j.gastro.2017.12.027.
Watson CJE, Jochmans I. From “gut feeling” to objectivity: machine preservation of the liver as a tool to assess organ viability. Curr Transpl Rep. 2018;5:72. https://doi.org/10.1007/s40472-018-0178-9.
Watson CJE, et al. Normothermic perfusion in the assessment and preservation of declined livers before transplantation: hyperoxia and vasoplegia-important lessons from the first 12 cases. Transplantation. 2017;101:1084. https://doi.org/10.1097/TP.0000000000001661.
Watson C, Hunt F, et al. In situ normothermic perfusion of livers in controlled circulatory death donation may prevent ischemic cholangiopathy and improve graft survival. Am J Transplant. 2018a. https://doi.org/10.1111/ajt.15241.
Watson C, Kosmoliaptsis V, et al. Observations on the ex situ perfusion of livers for transplantation. Am J Transplant. 2018b;18:2005. https://doi.org/10.1111/ajt.14687.
Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci. 2001;38:263. https://doi.org/10.1080/20014091084227.
Xia W, Ke Q, Wang Y, Feng X, Guo H, Wang W, Zhang M, Shen Y, Wu J, Xu X, Yan S, Zheng S. Donation after cardiac death liver transplantation: graft quality evaluation based on pretransplant liver biopsy. Liver Transpl. 2015 Jun;21(6):838–46.
Zhang WJ, Xia WL, Pan HY, Zheng SS. Postreperfusion hyperkalemia in liver transplantation using donation after cardiac death grafts with pathological changes. Hepatobiliary Pancreat Dis Int. 2016 Oct;15(5):487–92.
Disclosure
Authors have nothing to disclose.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Cortes-Cerisuelo, M., Schlegel, A. (2020). Donor Selection in DCD Liver Transplantation. In: Croome, K., Muiesan, P., Taner, C. (eds) Donation after Circulatory Death (DCD) Liver Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-030-46470-7_7
Download citation
DOI: https://doi.org/10.1007/978-3-030-46470-7_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-46469-1
Online ISBN: 978-3-030-46470-7
eBook Packages: MedicineMedicine (R0)